Rajesh Kumar

Rajesh Kumar Ph.D. joined Biohaven as Vice President of Chemistry, Manufacturing, and Controls (CMC) in 2018. He has more than 20 years of experience in developing immediate and controlled release pharmaceutical dosage forms, including drug-device combination products. He has extensive experience and clear understanding of the phase appropriate requirements for developing products from feasibility to commercialization. Prior to joining Biohaven, he served as a Senior Director of CMC at the Proprietary Products Division of Dr. Reddy’s Laboratories/Promius Pharma where he was responsible for CMC and device related development, overseeing external R&D and manufacturing partners for exploratory, clinical and commercial products. At Dr. Reddy’s he was responsible for the development and commercial manufacturing of Zembrace® (autoinjector). Dr. Kumar also spent 13+ years at Alkermes, Plc with increasing responsibilities and represented or led the CMC function in the development of multiple long acting complex injectable products including BYDUREON®, Aristada®, Risperdal® Consta® and Vivitrol®

Dr. Kumar obtained his Bachelor and Masters degree in Pharmacy from India and his Ph.D. in Pharmaceutical Sciences from Auburn University, AL.